期刊文献+

反义寡核苷酸技术的进展及在医学中的应用 被引量:2

在线阅读 下载PDF
导出
作者 邓超 包菊平
机构地区 江南大学医学系
出处 《海南医学院学报》 CAS 2003年第6期375-377,共3页 Journal of Hainan Medical University
  • 相关文献

参考文献15

二级参考文献67

  • 1王东,高奉浔,陈俐.骨肉瘤增殖细胞核抗原(PCNA)表达及其与临床病理和预后的关系[J].第三军医大学学报,1995,17(5):415-417. 被引量:4
  • 2陈协群,黄高升,杨平地,胡盛惠.bcl-2反义脱氧寡核苷酸对白血病细胞生长与凋亡易感性的影响[J].中国肿瘤临床,1997,24(1):9-12. 被引量:2
  • 3金冬雁.精编分子生物学实验指南(第1版)[M].北京:科学出版社,1998.284.
  • 4陈允硕.现代实用细胞化学技术(第1版)[M].上海:上海科学技术出版社,1996.98.
  • 5[1]Massague J, Hata A, Liu F. TGF - beta signalling through the Smad pathway[J]. Trends Cell Biol, 1997, 7:187 ~ 192.
  • 6[2]Chen SJ, Yuan WH, Lo S, et al. Interaction of Smad3 with a proximal Smad -binding element of human α2(Ⅰ) procollagen gene promoter required for transcriptional activation by TGF- β[J] . J Cellular Physiology, 2000, 138:381 ~ 392.
  • 7[3]Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins[J] . Nature,1997,390 (6659): 465 ~ 471.
  • 8[4]Nakao A, Afrakhte M, Moren A, et al. Identification of smad7, a TGF beta - inducible autagonist of TGF - beta signaling[J]. Nature,1997, 389(6651 ): 631 ~ 635.
  • 9[5]Imamura T, Takase M, Nishihara A, et al. Smad6 inhibits signalling by the TGF-beta superfamily[J] .Nature, 1997; 389(6651): 622 ~ 626.
  • 10[6]Schiffer M, Von Gersdorff G, Bitzer M, et al. Smad proteins and transforming growth factor beta signaling[J]. Kidney Int. 2000; 58(suppl 77): S45 ~ 52.

共引文献103

同被引文献22

  • 1张江安,谭升顺,王梅,彭振辉.C-myc反义寡核苷酸抗恶性黑素瘤作用机制初探[J].中国皮肤性病学杂志,2005,19(1):3-5. 被引量:1
  • 2王升启.反义寡核苷酸的化学修饰[J].生物化学与生物物理进展,1995,22(6):506-511. 被引量:10
  • 3肖刚,郭青玉,李睿,吴军正,邓晓红,张铁良.寡核苷酸转化变形链球菌方法的筛选[J].实用口腔医学杂志,2007,23(4):519-522. 被引量:4
  • 4Grover R, Pacifico MD, Wilson GD, et al. Use of oncogene expression as an independent prognostic marker for primary melanoma [ J ]. Ann Plast Surg,2003,50(2): 183 - 187.
  • 5Kraehn GM, Utikal J, Udart M, et al. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases[ J].Br J Cancer,2001,84( 1 ) :72 -79.
  • 6Chana JS,Grover R,Tulley P,et al. The c-myc oncogen e:use of a biological prognostic marker as a potential target for gene therapy in melanoma [J]. Br J Plast Surg,2002,55(8) :623 -627.
  • 7Stewart DA, Xu X, Thomas SD, et al. Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-myc expression and B16-F0 tumor progression [ J]. Nucleic Acids Res,2002,30( 11 ) :2565 -2574.
  • 8Heikkila R, Schwab G, Wickstrom E, et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1[J]. Nature,1987,328 (6129) :445 -449.
  • 9Loesche WJ. Role of Streptococcus nuuans in human dental decay [J]. Microbiol Rev, 1986, 50(4) :353 - 380.
  • 10Fujiwara T, Tamesada M, Bian Z, et al. Deletion and reinlroduction of glucosyltransferase genes of Streptococcus mutans and role of their gene products in sucrose dependenl cellular adherence [J]. Microb Pathog, 1996, 20 (4): 225 - 233.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部